PE20130639A1 - Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva - Google Patents

Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva

Info

Publication number
PE20130639A1
PE20130639A1 PE2012002492A PE2012002492A PE20130639A1 PE 20130639 A1 PE20130639 A1 PE 20130639A1 PE 2012002492 A PE2012002492 A PE 2012002492A PE 2012002492 A PE2012002492 A PE 2012002492A PE 20130639 A1 PE20130639 A1 PE 20130639A1
Authority
PE
Peru
Prior art keywords
bladder
cavity
treatment
methods
overactive bladder
Prior art date
Application number
PE2012002492A
Other languages
English (en)
Inventor
Anu Mahashabde
Jiaxiang Tsao
Original Assignee
Teva Womens Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45372075&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20130639(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Womens Health Inc filed Critical Teva Womens Health Inc
Publication of PE20130639A1 publication Critical patent/PE20130639A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/48—Devices for preventing wetting or pollution of the bed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Environmental & Geological Engineering (AREA)
  • Nursing (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Microscoopes, Condenser (AREA)

Abstract

SE REFIERE A UN METODO DE TRATAMIENTO DE UNA CONDICION ASOCIADA CON VEJIGA HIPERACTIVA TAL COMO EPISODIOS DE INCONTINENCIA URINARIA, URGENCIA URINARIA, FRECUENCIA URINARIA, CONTRACCIONES INVOLUNTARIAS DE LA VEJIGA Y RELAJACION DEL MUSCULO LISO DE LA VEJIGA, QUE COMPRENDE ADMINISTRAR A UNA HEMBRA UN DISPOSITIVO INTRAVAGINAL POR UN PERIODO DE 1 HORA A 6 MESES, EN DONDE EL DISPOSITIVO INTRAVAGINAL COMPRENDE: A) UNA PRIMERA MATRIZ ANULAR QUE COMPRENDE UNA CAVIDAD Y UNA PARED DE LA CAVIDAD QUE TIENE UN ESPESOR UNIFORME Y EN DONDE LA PARED DE LA CAVIDAD ABARCA LA CAVIDAD Y QUE ADEMAS PRESENTA UNA HENDIDURA; Y B) UNA SEGUNDA MATRIZ SITUADA EN LA CAVIDAD QUE COMPRENDE UN AGENTE ANTICOLINERGICO TAL COMO OXIBUTININA QUE SE LIBERA DESDE EL DISPOSITIVO INTRAVAGINAL CON UNA VELOCIDAD DE 0,1 A 50 MG/DIA
PE2012002492A 2010-06-22 2011-06-22 Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva PE20130639A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35732110P 2010-06-22 2010-06-22

Publications (1)

Publication Number Publication Date
PE20130639A1 true PE20130639A1 (es) 2013-06-15

Family

ID=45372075

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012002492A PE20130639A1 (es) 2010-06-22 2011-06-22 Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva

Country Status (16)

Country Link
US (1) US20120107385A1 (es)
EP (1) EP2585010A4 (es)
JP (1) JP2013534923A (es)
KR (1) KR20130118296A (es)
CN (1) CN103153245A (es)
AR (1) AR084700A1 (es)
AU (1) AU2011270995A1 (es)
CA (1) CA2803872A1 (es)
CL (2) CL2012003658A1 (es)
EA (1) EA201291299A1 (es)
MX (1) MX2013000002A (es)
PE (1) PE20130639A1 (es)
SG (2) SG186815A1 (es)
TW (1) TW201212910A (es)
WO (1) WO2011163356A2 (es)
ZA (1) ZA201209757B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106456951B (zh) * 2014-06-26 2021-11-05 塔里斯生物医药公司 包含弹性聚合物-药物基质系统的膀胱内药物递送装置及方法
WO2020028554A1 (en) * 2018-08-01 2020-02-06 Taris Biomedical Llc Methods of treating overactive bladder using trospium
WO2022225379A1 (ko) * 2021-04-23 2022-10-27 김승범 과민성 방광 치료 장치

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
ATE313422T1 (de) * 1998-05-01 2006-01-15 Duramed Pharmaceuticals Inc Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
WO2003053292A1 (en) * 2001-12-20 2003-07-03 Femmepharma, Inc. Vaginal delivery of drugs
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
CN1822815B (zh) * 2003-07-10 2012-04-11 沃纳奇尔科特(爱尔兰)有限公司 阴道内药物传递装置
CA2596933A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof

Also Published As

Publication number Publication date
SG10201504871PA (en) 2015-07-30
CN103153245A (zh) 2013-06-12
US20120107385A1 (en) 2012-05-03
WO2011163356A3 (en) 2012-03-22
CA2803872A1 (en) 2011-12-29
EP2585010A2 (en) 2013-05-01
WO2011163356A2 (en) 2011-12-29
SG186815A1 (en) 2013-02-28
KR20130118296A (ko) 2013-10-29
CL2013003488A1 (es) 2014-08-08
EP2585010A4 (en) 2014-10-01
TW201212910A (en) 2012-04-01
AU2011270995A1 (en) 2013-01-10
AR084700A1 (es) 2013-06-05
EA201291299A1 (ru) 2013-09-30
MX2013000002A (es) 2013-04-29
ZA201209757B (en) 2015-06-24
JP2013534923A (ja) 2013-09-09
CL2012003658A1 (es) 2014-02-14

Similar Documents

Publication Publication Date Title
MX357598B (es) Dispositivos intravaginales para administración de fármaco.
AR073460A1 (es) Dispositivo oftalmico con capacidad de administracion de agente terapeutico y metodo de formacion del mismo
AR082821A1 (es) Diferenciacion de las celulas madre pluripotentes
AR074528A1 (es) Dispositivos intravaginales con un soporte rigido, metodos para su fabricacion y sus usos
WO2014165308A3 (en) Microsphere drug delivery system for sustained intraocular release
DE602007010807D1 (de) Vorrichtung für kombinierte behandlung
EA201691193A1 (ru) Система доставки лекарственных средств
EP2419058A4 (en) VASCULAR ENDOPROSTHETICS HAVING CONTROLLED ELUTE
EP2493457A4 (en) SOLID DOSAGE FORM WITH RAPID DISSOLUTION
WO2014179568A3 (en) Two-layer ocular implant
MX2012003551A (es) Tabletas transformables via oral.
CO6450625A2 (es) Sistema intrauterino para uso en tratamiento médico
AR081113A1 (es) Liberacion pulsatil de medicamentos desde un tapon de punctum
MX2017016217A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
MX2020002465A (es) Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros transtornos del tracto urinario inferior.
PE20130639A1 (es) Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva
MY163383A (en) Degradable removable implant for the sustained release of an active compound
GEP201706648B (en) Co-micronisation product comprising selective progesterone-receptor modulator
WO2011139873A3 (en) Sleeve for stimulation of tissue regeneration
PE20130659A1 (es) Dispositivos intravaginales que comprenden agentes anticolinergicos y metodos para prepararlos
CN202654430U (zh) 易揭型膏药
MX2021009957A (es) Dispositivos de administracion de farmacos compartimentados.
Miyake et al. The Swelling of the External Ear in an Old Woman
CN202235830U (zh) 中医外科用的夹板
Hawkins Allergy: case report

Legal Events

Date Code Title Description
FC Refusal